Skip to content
drillr.ai
Sign up

YARW

Yarrow Bioscience Inc

NASDAQ · Healthcare · Biotechnology · US

$29.58
+2.53%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue482.0K570.0K501.0K424.0K477.0K
Cost of Revenue12.0K23.0K———
Gross Profit470.0K547.0K501.0K424.0K477.0K
Operating Expenses
R&D Expense9.8M19.2M30.9M16.3M18.4M
SG&A Expense10.6M11.1M13.2M13.4M16.4M
General & Admin Expense10.6M11.1M13.2M13.4M16.4M
Selling & Marketing Expense—————
Other Expenses(6.0K)(23.0K)———
Total Operating Expenses20.4M30.3M44.1M29.7M34.8M
Cost and Expenses20.4M30.3M44.1M29.7M34.8M
Operating Income (EBIT)(19.9M)(29.7M)(43.6M)(29.3M)(34.3M)
Non-Operating
Interest Income—————
Interest Expense—————
Net Interest Income—————
Other Non-Op Income/Expense1.1M3.0M3.8M1.4M363.0K
Non-Operating Income (excl Interest)(1.1M)(3.0M)(3.8M)(1.4M)(363.0K)
EBT (Pre-Tax Income)(18.9M)(26.7M)(39.8M)(27.9M)(33.9M)
Income Tax Expense4.0K4.0K4.0K—13.0K
Bottom Line
Net Income(18.7M)(26.5M)(39.8M)(28.5M)(23.2M)
Earnings from Cont. Ops(18.9M)(26.7M)(39.8M)(27.9M)(33.9M)
Earnings from Discont. Ops161.0K253.0K(27.0K)(580.0K)10.7M
Bottom Line Net Income(18.7M)(26.5M)(39.8M)(28.5M)(23.2M)
Per Share
Basic EPS($23.45)($30.96)($46.77)($138.48)($566.98)
Diluted EPS($23.45)($30.96)($46.77)($138.48)($566.98)
Revenue Per Share$0.56$0.67$0.59$2.06$7.49
Shares
Basic Shares Outstanding85800085536085178020546063719
Diluted Shares Outstanding85800085536085178020546063719
Profitability Metrics
EBITDA(18.8M)(26.7M)(39.8M)(27.9M)(33.9M)
D&A20.0K—4.0K—72.0K
EBIT(18.9M)(26.7M)(39.8M)(27.9M)(33.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026